Investor Presentaiton

Financial & Performance Highlights | Group Highlights Q3 2023 SG&A (USD 000) 19.6% 21.4% EBITDA (USD 000) 9.9% 9.9% +3% -5% 76,165 78,559 38,490 36,450 Net Profit (USD 000) 2.8% 0.7% 2.2% -23% 10,794 8,283 2,625 Q3 2022 Q3 2023 Q3 2022 Q3 2023 Q3 2022 Q3 2023 Q3 2023 Normalized X% Represents Margin in % of Revenue Consolidated Group SG&A increased by 3% YoY. Organic G&A (which excludes MyUS) declined by 9%, reflecting the Company's agility in cost management, reaching pre-pandemic levels. Notably, selling expenses for the organic business increased during the quarter, in line with the Company's strategy to increase sales competencies in key verticals across key markets. EBITDA margins were maintained at 10%, while EBITDA reached USD 36 million, a decline of 5% YoY in line with revenue indicating our success in managing costs and operational efficiencies. Normalized net income was USD 8.3 million, down 23% YoY. Net income was normalized for the currency translation impact and the increase in finance expense loans following the acquisition of MyUS in Q4 2022. Page 21

View entire presentation